Comment from the Academic Consortium for Integrative Medicine & Health on the CDC Clinical Practice Guideline for Prescribing Opioids-United States, 2022
Tick, Heather Nielsen, Arya Gardiner, Paula Simmons, Samantha Hansen, Kathryn A Dusek, Jeffery A
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
The Academic Consortium for Integrative Medicine & Health is a recognized leader in evidence-based integrative medicine (www.imconsortium.org). It is a member-supported organization with over 76 highly esteemed academic medical centers and health systems members; our vision is to transform the healthcare system by promoting access to evidence-based healthcare options for all. We whole heartily welcome the CDC’s support for evidence-based nonpharmacologic strategies as first line options for acute and chronic pain care, in alignment with the 2010 Army Surgeon General’s Pain Management Task Force Report, the American College of Physician’s Guidelines, and the Veterans Health Administration that encourage evidence-based nonpharmacologic options early in patient treatment protocols.
Source
Tick H, Nielsen A, Gardiner PM, Simmons S, Hansen KA, Dusek JA. Comment from the Academic Consortium for Integrative Medicine & Health on the CDC Clinical Practice Guideline for Prescribing Opioids-United States, 2022. Glob Adv Health Med. 2022 May 17;11:2164957X221104093. doi: 10.1177/2164957X221104093. PMID: 35601468; PMCID: PMC9121443.